Skip to main content
. Author manuscript; available in PMC: 2023 Apr 3.
Published in final edited form as: JAMA Psychiatry. 2023 Jan 1;80(1):77–83. doi: 10.1001/jamapsychiatry.2022.4101

Fig 1. Trends in psychedelic drug reform bills.

Fig 1.

Bills are categorized by what drug would be affected (A) and in what way (B). Curve in C shows the cumulative number of bills since January 1, 2019 based on the date the bill was first proposed. The map (D) only includes decriminalization bills (reducing or removing criminal penalties for possession of psychedelics). “Some Municipalities” indicates that municipal legislatures (e.g. Oakland, Santa Cruz, Arcata CA, Ann Arbor, DC, Washtenaw County MI, Somerville MA, Cambridge MA, Northampton MA) have passed legislation but not the state, and “Considering” means currently active bills (as of August 1, 2022). Colorado HB1344 (trigger law decriminalizing prescription MDMA contingent on FDA approval) was excluded.